7-Fluoro-6-nitro-4-hydroxyquinazoline: A Key Pharmaceutical Intermediate for Advanced Drug Synthesis

Unlock groundbreaking advancements in cancer treatment and drug discovery with this essential pharmaceutical intermediate.

Get a Quote & Sample

Key Advantages

Enhanced Efficacy in Cancer Therapeutics

Utilizing this 7-Fluoro-6-nitro-4-hydroxyquinazoline CAS 162012-69-3 enables researchers to develop more potent kinase inhibitors, leading to improved patient outcomes in cancer treatment.

Streamlined Drug Development Processes

The consistent purity and well-defined chemical properties of 7-Fluoro-6-nitro-4-hydroxyquinazoline 98% simplify complex synthesis pathways, accelerating the drug development timeline.

Foundation for Novel Antitumor Drugs

This intermediate serves as a foundational element for the synthesis of novel antitumor drugs, opening new avenues in combating challenging diseases.

Key Applications

Pharmaceutical Synthesis

A critical pharmaceutical intermediate, essential for the meticulous synthesis of advanced drug molecules and targeted therapies.

Oncology Drug Development

Plays a pivotal role in the creation of cutting-edge anticancer drugs, contributing to the fight against various forms of cancer.

Kinase Inhibitor Research

Indispensable for research into kinase inhibitors, furthering our understanding and development of treatments for diseases driven by aberrant kinase activity.

Advanced Chemical Intermediates

Serves as a high-value fine chemical, vital for complex organic synthesis in cutting-edge research and industrial applications.